India’s core sectors output up by 5.4% in November 2022
The Hindu
Steel output grew at the fastest pace in six months at 10.8%, but production levels were 2.35% lower than October 2022
India’s eight core sectors’ output growth rebounded to 5.4% in November from a revised estimate of a 0.9% uptick in October, although overall production levels in November 2022 remained the same as October.
Cement output recovered sharply from a 4.3% contraction in October to jump 28.6% in November, while coal and electricity production levels accelerated to rise 12.3% and 12.1%, respectively.
Steel output grew at the fastest pace in six months at 10.8%, but production levels were 2.35% lower than October 2022. Fertilisers’ production grew 6.4%.
Crude oil output contracted for the sixth successive month, shrinking 1.1% in November, while natural gas production dropped 0.7%, the fifth month of contraction in a row.
Rupee hits all-time low at 85.20 against USD due to strong greenback, rising crude oil prices, and weak domestic markets.
Viatris faces U.S. FDA import alert for products from Indore plant, exceptions made for certain shortages.
xAI’s Grok may soon come to an iOS app as the company announced its Series C funding round of $6 billion.
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Equity markets fluctuate as Sensex and Nifty rise initially, then fall; global markets and oil prices also discussed.
Microsoft has been working on adding internal and third-party AI models to power Microsoft 365 Copilot.
China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.
India's controversial popcorn tax system sparks outrage and criticism, with opposition questioning the complex GST rates.
ICAI President investigates auditing lapses at Byju's, disciplinary committee probing, details undisclosed, part of ongoing investigations.
Sensex and Nifty rebound sharply after steep decline, driven by value buying, bluechip stocks, and global market rally.
AS-IT-IS Nutrition aims for ₹300 crore GMV in 2025 with ATOM range, endorsed by Ravindra Jadeja.